𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Incidence of extraovarian primary cancers in the United States, 1992–1997

✍ Scribed by Steven D. Roffers; Xiao Cheng Wu; Carol Hahn Johnson; Catherine N. Correa; Holly L. Howe


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
73 KB
Volume
97
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


T he accurate classification of the primary site and histology of reportable malignancies by cancer registrars requires careful review of the medical records, especially pathology and surgery reports. The pathologic distinction between cancer of the ovary and cancer of extraovarian tissue can be difficult. Extraovarian primary peritoneal carcinoma (EOPPC) is a cancer that arises in the peritoneum and mimics epithelial ovarian cancer in terms of symptoms, microscopic appearance, pattern of spread, treatment, and prognosis. [1][2][3] Primary serous carcinoma of the endometrium, fallopian tubes, broad ligament, or other specified female genital organs also may be misdiagnosed as primary epithelial ovarian cancer. 4 Little is known about the epidemiologies of EOPPC and other extraovarian cancers, such as mucoepidermoid carcinoma, cystadenocarcinoma, serous cystadenocarcinoma, and serous cystadenoma of borderline malignancy, that typically arise in ovarian tissue. Published reports are limited to descriptions of small case series. [1][2][3][5][6][7] The purpose of this report is to describe the incidence and distribution of selected extraovarian primary cancers by age, race and ethnicity, histology, grade, and stage. Three subsets of potentially misclassified extraovarian cancers that are known to influence the incidence of ovarian cancer were identified: 1) extraovarian cancers of the peritoneum; 2) extraovarian cancers of the endometrium; and 3) extraovarian cancers diagnosed in nonperitoneal and nonendometrial tissue of the corpus uteri, uterus, or other female genital tract organs. The extraovarian cancer subsets were drawn from women diagnosed with cancer between 1992 and 1997 in selected areas of the United States.

EOPPC: extraovarian primary peritoneal carcinoma; ESC: endometrial serous cystadenocarcinoma; EONPPC: extraovarian nonperitoneal primary carcinoma. a Includes only cancers with selected histology types (8430, 8440, 8441, and 8442).


📜 SIMILAR VOLUMES


Incidence of ovarian cancer by race and
✍ Marc T. Goodman; Holly L. Howe; Ko Hui Tung; Joellyn Hotes; Barry A. Miller; Ste 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB

O varian cancer is the fifth most common cancer among U.S. women. 1 An estimated 23,400 new cases were expected to be diagnosed in the U.S. in 2001. As is the case for breast and endometrial cancers, ovarian cancer is more common among women in northern and central Europe, and North America compare

Descriptive epidemiology of ovarian canc
✍ Marc T. Goodman; Holly L. Howe 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

T he North American Association of Central Cancer Registries (NAACCR), formerly the American Association of Central Cancer Registries, was formed in 1987 to create registration standards and to provide a forum for the promotion and advancement of registry activities. The NAACCR's activities have gro

Stage at diagnosis of ovarian cancer in
✍ Marc T. Goodman; Catherine N. Correa; Ko-Hui Tung; Steven D. Roffers; Xiao Cheng 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB 👁 1 views

R%: relative percentage. a Malignant ovarian tumors exclude serous cystadenoma (8442), papillary cystadenoma (8451), papillary serous cystadenoma (8462), mucinous cystadenoma (8472), and papillary mucinous cystadenoma (8473). b Rates are per 100,000 and are age-adjusted to the 1970 United States sta

Hepatoblastoma incidence in the United S
✍ Ross, Julie A.; Gurney, James G. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 19 KB 👁 2 views

Background. There is recent evidence to suggest that extremely low birth weight is associated with the occurrence of hepatoblastoma. Procedure. In light of this possibility, we evaluated trends in hepatoblastoma incidence in the United States among children age 4 years and younger. Results. We fou